A Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Refractory Mucocutaneous Herpes Simplex Disease in Patients With AIDS

Johns Hopkins Hosp, Baltimore

Univ of North Carolina Hosps, Chapel Hill

Rush Presbyterian - Saint Luke's Med Ctr, Chicago

Park Plaza Hosp, Houston

Los Angeles County - USC Med Ctr, Los Angeles

UCSF - San Francisco Gen Hosp, San Francisco

Mount Zion Med Ctr / UCSF, San Francisco

Univ of Washington / Viral Disease Clinic, Seattle

Univ of British Columbia / Univ Hosp, Vancouver